fda compounding semaglutide warning september 2025 2, 2025: U.S. restrictions have stemmed a flood of compounded and tirzepatide – Partnership for Safe Medicines FDA to Restrict Ingredients Used

Medicaid programs in California, New Hampshire, Pennsylvania and South Carolina have eliminated coverage of the drugs for weight loss, because the expense strained state budgets

The most significant concern involves systemic infection (bacteremia or fungemia) in immunocompromised patients, though this remains rare with quality-controlled products

The back of the upper arm The triceps area offers a viable third option, though it requires either flexible reach or assistance from another person

PCOS is only a problem for overweight or obese women PCOS can affect women of all body types, including those who are lean or at a healthy weight

The forgotten members of the glucagon family

Hypoaminoacidemia underpins glucagon-mediated energy expenditure and weight loss